-+ 0.00%
-+ 0.00%
-+ 0.00%

Cumberland Pharmaceuticals And Qureight Partner To Advance Idiopathic Pulmonary Fibrosis Treatment Research

Benzinga·05/13/2025 20:17:26
Listen to the news

Cumberland leveraging Qureight's deep-learning AI platform 

for its Phase II FIGHTING FIBROSIS™ clinical trial